Buy Alnylam Pharmaceuticals Inc. Stocks - View ALNY Live Price (2026)

ALNY

TYPE Stocks

GROUP Stocks

BASE Alnylam Phar...

SECOND

<% (signals.list.current.rate).substr(0,7) %>

<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)

MARKETS TREND

OPEN

<% (signals.list.current.openrate).substr(0,9) %>

HIGH

<% (signals.list.current.high).substr(0,9) %>

LOW

<% (signals.list.current.low).substr(0,9) %>

START TRADING

Multi Charts

Add to Watchlist

ALNY Signals

DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM

ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM

<% signal.pair %> (<% signal.rate %>) <% signal.action %>

<% signal.status %>

<% signal.analyst %>

Long Term

Entry Price

Stop Loss

Take Profit

PREMIUM ONLY

<% signal.stopLoss %> N/A

PREMIUM ONLY

<% signal.takeProfit %> N/A

PREMIUM ONLY

GO PREMIUM

TRADE NOW

GET READY

<% signal.analyst %>

<% signal.comment %>

Description

<% signal.description %>

LATEST ANALYSIS

<% item.time_ago %> Ago

<% item.title %>

<% item.deltaTime %>

Full Analysis Feed

Last Updated: Apr 02, 2026 03:05:50 PM (GMT)

ALNY: The current market price is 321.07, reflecting a decrease of 2.33%.

Support and Resistance Levels The pivot point is 320.89667, with support levels at 313.06333, 308.35667, and 300.52333, and resistance levels at 325.60333, 333.43667, and 338.14333.

Indicators The current RSI is 11.4, indicating a strong bearish trend since it has fallen from historical highs. The ATR is at 1.33213, suggesting increased volatility. The 5-day SMA is 326.538, the 10-day SMA is 327.634, and the 20-day SMA is 328.3565, all indicating a downward trend. The MACD shows a bearish crossover, with current values of MACD -1.28511 and signal -0.54581. The current Parabolic SAR is 336, further indicating a bearish trend.

Market Sentiment With the current price below the pivot point of 320.89667 and bearish indicators, a continued downtrend is expected.

ALNY Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>

Market Trend

Strong Sell

Sell

Neutral

Buy

Strong Buy

Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>

Strong Sell

Sell

Neutral

Buy

Strong Buy

Trend Indicators

NAME

VALUE

ACTION

Bollinger Bands

UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>

MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>

LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>

Sell

Buy

Parabolic SAR

<% indicators.data[indicators.interval.active].sar.value %>

Sell

Buy

Standard Deviation

<% indicators.data[indicators.interval.active].stddev.value %>

High Volatility

Low Volatility

Oscillators

NAME

VALUE

ACTION

RSI(14)

<% indicators.data[indicators.interval.active].rsi.value %>

Sell

Buy

MACD(12,26)

<% indicators.data[indicators.interval.active].macd.value %>

Buy

Sell

Neutral

ATR

<% indicators.data[indicators.interval.active].atr.value %>

High Volatility

Low Volatility

STOCH(9,6)

<% indicators.data[indicators.interval.active].stochastics.value %>

Buy

Sell

ADX

<% indicators.data[indicators.interval.active].adx.value %>

High Volatility

Low Volatility

Moving Averages

PERIOD

SIMPLE

EXPONENTIAL

MA5

<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell

MA10

<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell

MA20

<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell

MA50

<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell

MA100

<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT

CLASSIC

FIBONACCI

CAMARILLA

WOODIE

<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (ALNY) Alnylam Pharmaceuticals Inc.

Company Background

Alnylam Pharmaceuticals Inc. (Symbol: ALNY) is a pioneering biotechnology firm dedicated to transforming the treatment landscape for genetically-defined diseases. Founded in 2002 and headquartered in Cambridge, Massachusetts, Alnylam specializes in RNA interference (RNAi) technology, which enables the silencing of disease-causing genes at the RNA level. This innovative approach has positioned the company as a leader in developing therapies for rare and prevalent diseases associated with genetic mutations. With a commitment to scientific excellence and patient-centric solutions, Alnylam has become synonymous with groundbreaking advancements in the field of genetic medicine.

Market Position

Alnylam Pharmaceuticals holds a prominent position in the biopharmaceutical industry, particularly within the RNAi therapeutics market. With a robust pipeline of investigational and commercial products, the company has successfully launched several therapies, including ONPATTRO® (patisiran), which was the first-ever RNAi therapy approved for the treatment of hereditary transthyretin-mediated amyloidosis. This significant milestone not only underscores Alnylam's innovative capabilities but also highlights its dedication to addressing unmet medical needs. The company continues to expand its product offerings and explore new indications, reinforcing its status as a frontrunner in biotechnology.

Key Financial Highlights

Alnylam has demonstrated strong financial performance, supported by its innovative product portfolio and strategic partnerships. As of October 2023, the company reported significant revenue growth driven by the sales of its RNAi therapeutics. Alnylam's financial stability is further enhanced by collaborations with major pharmaceutical companies, which provide both funding and shared expertise. With a strong balance sheet and a growing market presence, Alnylam is well-positioned for future growth, focusing on expanding its pipeline and advancing new therapies through clinical trials. The company remains committed to exploring additional applications of its RNAi technology, thereby solidifying its leadership in the biotechnology sector.

Check all ALNY conversion rates

Related Stocks

BNTX

BioNTech SE

Industry Biotechnology

Exchange NASDAQ

TECH

Bio-Techne Corporation

Industry Biotechnology

Exchange NASDAQ

ROIV

Roivant Sciences Ltd

Industry Biotechnology

Exchange NASDAQ